Evidence map›Paper›PMID 35173641›Full record

ArticleFrontiers in psychiatry2022

European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study.

Sonia Dollfus, Armida Mucci, Giulia M Giordano, István Bitter, Stephen F Austin, Camille Delouche, Andreas Erfurth, W Wolfgang Fleischhacker, Larisa Movina, Birte Glenthøj and 14 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Early career psychiatrists' ability to evaluate and manage negative symptoms of schizophrenia - Results from a European survey.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Promoting schizophrenia research in Europe: the contribution of the European Group for Research in Schizophrenia.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Sonia DollfusService de Psychiatrie, CHU de Caen, Caen, France.
Armida MucciDepartment of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.
Giulia M GiordanoDepartment of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.
István BitterDepartment of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
Stephen F AustinPsychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark.
Camille DeloucheService de Psychiatrie, CHU de Caen, Caen, France.
Andreas Erfurth1st Department of Psychiatry and Psychotherapeutic Medicine, Klinik Hietzing, Vienna, Austria.
W Wolfgang FleischhackerDivision of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University Innsbruck, Innsbruck, Austria.
Larisa MovinaDepartment of Psychotic Spectrum Disorders, Moscow Research Institute of Psychiatry, Moscow, Russia.
Birte GlenthøjCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark.
Karoline GütterDepartment of Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
Alex HoferDivision of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University Innsbruck, Innsbruck, Austria.
Jan HubenakPsychiatric Department, Charles University Medical School and Faculty Hospital Hradec Králové, Hradec Králové, Czechia.
Stefan KaiserAdult Psychiatry Division, Department of Psychiatry, University of Geneva Hospitals, Geneva, Switzerland.
Jan LibigerPsychiatric Department, Charles University Medical School and Faculty Hospital Hradec Králové, Hradec Králové, Czechia.
Ingrid MelleNORMENT Centre, Institute of Clinical Psychiatry, Oslo University Hospital, University of Oslo, Oslo, Norway.
Mette Ø NielsenCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark.
Oleg PapsuevDepartment of Psychotic Spectrum Disorders, Moscow Research Institute of Psychiatry, Moscow, Russia.
Janusz K RybakowskiDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Gabriele SachsDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Alp ÜçokPsychotic Disorders Research Program, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Francesco BrandoDepartment of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.
Pawel WojciakDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Silvana GalderisiDepartment of Psychiatry, University of Campania Luigi Vanvitelli, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNegative symptoms are usually evaluated with scales based on observer ratings and up to now self-assessments have been overlooked. The aim of this paper was to validate the Self-evaluation of Negative Symptoms (SNS) in a large European sample coming from 12 countries. We wanted to demonstrate: (1) good convergent and divergent validities; (2) relationships between SNS scores and patients' functional outcome; (3) the capacity of the SNS compared to the Brief Negative Symptom Scale (BNSS) to detect negative symptoms; and (4) a five-domain construct in relation to the 5 consensus domains (social withdrawal, anhedonia, alogia, avolition, blunted affect) as the best latent structure of SNS.

methodsTwo hundred forty-five subjects with a DSM-IV diagnosis of schizophrenia completed the SNS, the Positive and Negative Syndrome Scale (PANSS), the BNSS, the Calgary Depression Scale for Schizophrenia (CDSS), and the Personal and Social Performance (PSP) scale. Spearman's Rho correlations, confirmatory factor analysis investigating 4 models of the latent structure of SNS and stepwise multiple regression were performed.

resultsSignificant positive correlations were observed between the total score of the SNS and the total scores of the PANSS negative subscale (

conclusionIn a large European multicentric sample, this study demonstrated that the SNS has: (1) good psychometric properties with good convergent and divergent validities; (2) a five-factor latent structure; (3) an association with patients' functional outcome; and (4) the capacity to identify subjects with negative symptoms that is close to the BNSS and superior to the PANSS negative subscale.

Indexed as

BNSSconfirmatory factor analysisnegative symptomsschizophreniaself-assessmentSNS

Identifiers

PMID35173641
PMCPMC8841841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.